Genetic testing can reveal important information about prostate cancer risk, both for the man diagnosed and for his family. But a new study suggests many people are walking into this decision with significant gaps in their understanding. Researchers talked to a small group of men with prostate cancer, their family members, and their doctors to understand what they know and what worries them.
They found that knowledge about this type of medicine—called precision medicine—was generally low. The strongest reason people gave for wanting a genetic test was to understand the risk for their children and other relatives. However, the biggest concern holding them back was the fear that a positive result could lead to discrimination from life insurance companies.
To help, the researchers created an information toolkit. Doctors found its purpose clearer than patients did. Some patients struggled to imagine how they would have used this information when they were first diagnosed or when they were thinking about their genetic risk. The study was small and its findings are based on conversations and surveys, not on measuring health outcomes. The toolkit itself needs more testing to make sure it's accessible and helpful for people with different reading levels and cultural backgrounds.
